Recent Advances in Cardiovascular Drug Discovery (Discontinued)
Formerly: Recent Patents on Cardiovascular Drug Discovery
Volume 10, 2 Issues, 2015
ISSN: 2212-3962 (Online)
ISSN: 1574-8901 (Print)
This journal supports open access
ISSN: 2212-3962 (Online)
ISSN: 1574-8901 (Print)
This journal supports open access
 |
Aims & Scope
Recent Advances in Cardiovascular Drug Discovery publishes review and research articles, drug clinical trial studies and guest edited thematic issues on cardiovascular drug discovery. The scope covers but is not limited to, medicinal chemistry, pharmacology, genomics, biochemistry, novel bioactive compounds, analogs & targets, and important patents in cardiovascular drug discovery research.
Recent Advances in Cardiovascular Drug Discovery (Discontinued)
,Volume 10
-Number 1
Meet Our Editorial Board Member
Preface
Preface: Facing New Challenges in Cardiovascular Disease, When the Pressure Goes Up and the Pump Goes Astray
, 10(1): 2 - 3Raouf A Khalil
DOI: 10.2174/157489011001160111165714
Preface: Facing New Challenges in Cardiovascular Disease, When the Pressure Goes Up and the Pump Goes Astray
Hypertension in Type 2 Diabetes Mellitus: Do We Need to Redefine the Role of Sulfonylureas?
, 10(1): 4 - 9Devindra Sehra and Sudhish Sehra
DOI: 10.2174/157489011001160111154536
Hypertension in Type 2 Diabetes Mellitus: Do We Need to Redefine the Role of Sulfonylureas?
Basic and Clinical Research Against Advanced Glycation End Products (AGEs): New Compounds to Tackle Cardiovascular Disease and Diabetic Complications
, 10(1): 10 - 33Antonio Nenna, Cristiano Spadaccio, Mario Lusini, Luca Ulianich, Massimo Chello and Francesco Nappi
DOI: 10.2174/1574890110666151104120039
Basic and Clinical Research Against Advanced Glycation End Products (AGEs): New Compounds to Tackle Cardiovascular Disease and Diabetic Complications
The Challenges of Blood Pressure Control in Dialysis Patients
, 10(1): 34 - 59Vito M. Campese and Ravi Lakdawala
DOI: 10.2174/1574890110666151116144725
The Challenges of Blood Pressure Control in Dialysis Patients
NOAC or warfarin for Atrial Fibrillation: does time in therapeutic range matter?
, 10(1): 60 - 64Ioannis Merinopoulos, Paul Venables, Isobel Chalmers and Vassilios Vassiliou
DOI: 10.2174/1574890110666150914121856
NOAC or warfarin for Atrial Fibrillation: does time in therapeutic range matter?
Combination of Vasopressin –Epinephrine as a Novel Candidate in Patients with Cardiac Arrest
, 10(1): 65 - 69Nasim Ghafourian, Nader H. Maniae, Morovat Taherikalani, Maryam Mehrazi, Mahnaz Hossieni, Firouzeh Valian, Shahriar Karami, Yazdan Rahmatian and Nader Tavakoli
DOI: 10.2174/157489011001160111163856
Combination of Vasopressin –Epinephrine as a Novel Candidate in Patients with Cardiac Arrest
Cardiovascular Implantable Electronic Device Infections: Risk Scoring and Role of Antibiotic Envelope in Prevention
, 10(1): 70 - 76Nasir Shariff, Tauseef Akthar, Eathar Razak, Nathan Segerson and David Schwartzman
DOI: 10.2174/1574890110666151104120207
Cardiovascular Implantable Electronic Device Infections: Risk Scoring and Role of Antibiotic Envelope in Prevention
Articles Ahead of Print
There are currently no Articles Ahead of Print available for this journal.
Abstracts Ahead of Print
There are currently no Abstracts Ahead of Print available for this journal.
Published Contents
- Recent Advances in Cardiovascular Drug Discovery (Discontinued), Volume 10, 2015
- Recent Advances in Cardiovascular Drug Discovery (Discontinued), Volume 9, 2014
- Recent Patents on Cardiovascular Drug Discovery (Discontinued), Volume 9, 2014
- Recent Patents on Cardiovascular Drug Discovery (Discontinued), Volume 8, 2013
- Recent Patents on Cardiovascular Drug Discovery (Discontinued), Volume 7, 2012
- Recent Patents on Cardiovascular Drug Discovery (Discontinued), Volume 6, 2011
- Recent Patents on Cardiovascular Drug Discovery (Discontinued), Volume 5, 2010
- Recent Patents on Cardiovascular Drug Discovery (Discontinued), Volume 4, 2009
- Recent Patents on Cardiovascular Drug Discovery (Discontinued), Volume 3, 2008
- Recent Patents on Cardiovascular Drug Discovery (Discontinued), Volume 2, 2007
- Recent Patents on Cardiovascular Drug Discovery (Discontinued), Volume 1, 2006
Editor's Choice
Hypertension in Type 2 Diabetes Mellitus: Do We Need to Redefine the Role of Sulfonylureas?
, 2015; 10(1): 4 - 9Devindra Sehra and Sudhish Sehra
DOI: 10.2174/157489011001160111154536
Anti-VEGF Anticancer Drugs: Mind the Hypertension
, 2014; 9(2): 63 - 72Vasiliki Katsi, Zerdes Ioannis*, Manolakou Stavroula, Makris Thomas, Nihoyannopoulos Petros, Tousoulis Dimitris and Kallikazaros Ioannis
DOI: 10.2174/1574890110999150604114127
Open Access Articles
Most Cited Articles
Most Accessed Articles
Cardiovascular Implantable Electronic Device Infections: Risk Scoring and Role of Antibiotic Envelope in Prevention
, 2015; 10(1): 70-76.Nasir Shariff, Tauseef Akthar, Eathar Razak, Nathan Segerson and David Schwartzman
DOI: 10.2174/1574890110666151104120207
Basic and Clinical Research Against Advanced Glycation End Products (AGEs): New Compounds to Tackle Cardiovascular Disease and Diabetic Complications
, 2015; 10(1): 10-33.Antonio Nenna, Cristiano Spadaccio, Mario Lusini, Luca Ulianich, Massimo Chello and Francesco Nappi
DOI: 10.2174/1574890110666151104120039
The Challenges of Blood Pressure Control in Dialysis Patients
, 2015; 10(1): 34-59.Vito M. Campese and Ravi Lakdawala
DOI: 10.2174/1574890110666151116144725
ω-3 Polyunsaturated Fatty Acids Effects on the Cardiometabolic Syndrome and their Role in Cardiovascular Disease Prevention: An Update from the Recent Literature
, 2014; 9(2): 78-96.GianLuca Colussi, Cristiana Catena and Leonardo A. Sechi
DOI: 10.2174/1574890110666150724115111
Hypertension in Type 2 Diabetes Mellitus: Do We Need to Redefine the Role of Sulfonylureas?
, 2015; 10(1): 4-9.Devindra Sehra and Sudhish Sehra
DOI: 10.2174/157489011001160111154536
Primary and Secondary Prevention of Acute Coronary Syndromes: The Role of the Statins
, 2014; 9(2): 97-105.Evangelos Diamantis, Theodoros Troupis, Antonios Mazarakis, Giorgos Kyriakos, S Diamanti, Georgios Troupis and Panagiotis Skandalakis
DOI: 10.2174/1574890110666150708112349
Anti-VEGF Anticancer Drugs: Mind the Hypertension
, 2014; 9(2): 63-72.Vasiliki Katsi, Zerdes Ioannis*, Manolakou Stavroula, Makris Thomas, Nihoyannopoulos Petros, Tousoulis Dimitris and Kallikazaros Ioannis
DOI: 10.2174/1574890110999150604114127
Vorapaxar, a Protease-Activated Receptor-1 Antagonist, a Double –Edged Sword!
, 2014; 9(2): 73-77.Bharti Bhandari and Bharati Mehta
DOI: 10.2174/1574890110666150624100815
NOAC or warfarin for Atrial Fibrillation: does time in therapeutic range matter?
, 2015; 10(1): 60-64.Ioannis Merinopoulos, Paul Venables, Isobel Chalmers and Vassilios Vassiliou
DOI: 10.2174/1574890110666150914121856
Combination of Vasopressin –Epinephrine as a Novel Candidate in Patients with Cardiac Arrest
, 2015; 10(1): 65-69.Nasim Ghafourian, Nader H. Maniae, Morovat Taherikalani, Maryam Mehrazi, Mahnaz Hossieni, Firouzeh Valian, Shahriar Karami, Yazdan Rahmatian and Nader Tavakoli
DOI: 10.2174/157489011001160111163856
Co-Editors
Paul J. Higgins (USA)
Raouf A. Khalil (USA)
Raouf A. Khalil (USA)
Quick Links
Advertisement
Webmaster Contact: info@benthamscience.net